$2.63 Billion is the total value of SUVRETTA CAPITAL MANAGEMENT, LLC's 89 reported holdings in Q2 2022. The portfolio turnover from Q1 2022 to Q2 2022 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| UNH | UNITEDHEALTH GROUP INC | $123,783,000 | +0.7% | 240,997 | 0.0% | 4.71% | +25.4% | |
| OTIS | OTIS WORLDWIDE CORP | $91,693,000 | -8.2% | 1,297,480 | 0.0% | 3.49% | +14.3% | |
| PNT | POINT BIOPHARMA GLOBAL INC | $20,528,000 | -14.6% | 3,014,408 | 0.0% | 0.78% | +6.4% | |
| PHVS | PHARVARIS N V | $18,289,000 | +21.9% | 827,540 | 0.0% | 0.70% | +51.7% | |
| MREO | MEREO BIOPHARMA GROUP PLCads | $10,239,000 | 0.0% | 9,142,067 | 0.0% | 0.39% | +24.3% | |
| BHVN | BIOHAVEN PHARMACTL HLDG CO L | $8,980,000 | +22.9% | 61,631 | 0.0% | 0.34% | +52.9% | |
| OTIC | OTONOMY INC | $6,540,000 | -13.3% | 3,144,196 | 0.0% | 0.25% | +7.8% | |
| RACB | RESEARCH ALLIANCE CORP II | $4,900,000 | +0.3% | 500,000 | 0.0% | 0.19% | +24.8% | |
| IFRX | INFLARX NV | $4,763,000 | -20.8% | 3,285,000 | 0.0% | 0.18% | -1.6% | |
| BOLT | BOLT BIOTHERAPEUTICS INC | $4,550,000 | -25.5% | 2,230,250 | 0.0% | 0.17% | -7.5% | |
| GMTX | GEMINI THERAPEUTICS INC | $4,009,000 | +21.6% | 2,372,267 | 0.0% | 0.15% | +50.5% | |
| AMAM | AMBRX BIOPHARMA INCsponsored ads | $3,953,000 | -35.7% | 1,491,832 | 0.0% | 0.15% | -20.2% | |
| TERN | TERNS PHARMACEUTICALS INC | $3,072,000 | -16.5% | 1,238,800 | 0.0% | 0.12% | +4.5% | |
| EBAC | EUROPEAN BIOTECH ACQUTN CORP | $2,937,000 | +0.5% | 300,000 | 0.0% | 0.11% | +25.8% | |
| OMEG | OMEGA ALPHA SPACcl a | $2,955,000 | +0.3% | 300,000 | 0.0% | 0.11% | +24.4% | |
| ROIVANT SCIENCES LTD | $2,774,000 | -17.6% | 681,528 | 0.0% | 0.10% | +1.9% | ||
| MOLN | MOLECULAR PARTNERS AGads | $2,712,000 | -67.0% | 400,000 | 0.0% | 0.10% | -59.0% | |
| SIOX | SIO GENE THERAPIES INC | $2,130,000 | -46.2% | 5,914,000 | 0.0% | 0.08% | -33.1% | |
| AGLE | AEGLEA BIOTHERAPEUTICS INC | $2,051,000 | -78.0% | 4,059,894 | 0.0% | 0.08% | -72.6% | |
| TMPM | TURMERIC ACQUISITION CORPcl a | $1,986,000 | +0.8% | 200,000 | 0.0% | 0.08% | +26.7% | |
| BLSA | BCLS ACQUISITION CORP | $1,980,000 | +0.3% | 200,000 | 0.0% | 0.08% | +25.0% | |
| ENTRADA THERAPEUTICS INC | $1,291,000 | +29.7% | 106,000 | 0.0% | 0.05% | +63.3% | ||
| IMMUNEERING CORP | $1,082,000 | -16.4% | 200,000 | 0.0% | 0.04% | +2.5% | ||
| EUCR | EUCRATES BIOMEDICAL ACQU COR | $990,000 | +0.6% | 99,999 | 0.0% | 0.04% | +26.7% | |
| BNTC | BENITEC BIOPHARMA INC | $892,000 | -50.3% | 769,000 | 0.0% | 0.03% | -38.2% | |
| FLAC | FRAZIER LIFESCIENCES ACQU CO | $864,000 | +0.5% | 87,498 | 0.0% | 0.03% | +26.9% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-08-15
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| ADOBE SYSTEMS INCORPORATED | 33 | Q4 2021 | 13.2% |
| CONSTELLATION BRANDS INC | 20 | Q4 2018 | 10.9% |
| AMAZON COM INC | 20 | Q3 2023 | 8.0% |
| UNITEDHEALTH GROUP INC | 20 | Q3 2023 | 5.7% |
| IQVIA HLDGS INC | 19 | Q3 2023 | 7.3% |
| RESTAURANT BRANDS INTL INC | 18 | Q3 2019 | 8.9% |
| UNION PAC CORP | 17 | Q2 2023 | 5.1% |
| META PLATFORMS INC | 16 | Q3 2023 | 10.9% |
| COPART INC | 15 | Q4 2021 | 2.3% |
| SUTRO BIOPHARMA INC | 15 | Q3 2023 | 1.9% |
View SUVRETTA CAPITAL MANAGEMENT, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Zura Bio Ltd | June 15, 2023 | 2,850,000 | 6.6% |
| InflaRx N.V. | April 24, 2023 | 5,733,910 | 10.3% |
| Benitec Biopharma Inc. | April 18, 2023 | 3,020,214 | 10.0% |
| Aeglea BioTherapeutics, Inc. | February 13, 2023 | 6,376,373 | 10.0% |
| Bolt Biotherapeutics, Inc.Sold out | February 13, 2023 | 0 | 0.0% |
| Cano Health, Inc.Sold out | February 13, 2023 | 0 | 0.0% |
| CHIMERIX INCSold out | February 13, 2023 | 0 | 0.0% |
| Disc Medicine, Inc.Sold out | February 13, 2023 | 0 | 0.0% |
| OTONOMY, INC.Sold out | February 13, 2023 | 0 | 0.0% |
| Sio Gene Therapies Inc.Sold out | February 13, 2023 | 0 | 0.0% |
View SUVRETTA CAPITAL MANAGEMENT, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-05-15 |
| SC 13G | 2024-05-13 |
| 3 | 2024-05-02 |
| SC 13D | 2024-04-29 |
| SC 13G | 2024-04-15 |
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-13 |
| SC 13G/A | 2024-02-13 |
| SC 13G/A | 2024-02-13 |
| SC 13G/A | 2024-02-13 |
View SUVRETTA CAPITAL MANAGEMENT, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.